Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02761720 · ClinicalTrials.gov registry record
Mobile App for Mood in Pregnancy (Ginger iO)
A clinical trial of Depression and Mood Disorders, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 72
- Enrollment target
- 1
- Study location
NCT02761720: Completed study of Depression and Mood Disorders, sponsored by University of Pennsylvania.
NCT02761720 is a study of Depression and Mood Disorders that has completed, run by University of Pennsylvania. The registered enrollment target is 72 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02761720, a study of Depression and Mood Disorders, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The Mobile Mood Tracking App study is a small randomized trial of acceptability and usability of a mobile phone mood tracking application (mobile app) among women with depressed mood in pregnancy. The study will be assessing the perceived value and usability of this tool in pregnancy over eight weeks to test whether women using this app are more likely to receive assessments and treatments of depressed mood than women not using it.
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (1)
Pennsylvania
- Dickens Center for Women's Health at the Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2015-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02761720
The ClinicalTrials.gov registry entry for NCT02761720 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (91% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT02761720 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02761720 about?
NCT02761720 is a clinical study titled "Mobile App for Mood in Pregnancy (Ginger iO)". The Mobile Mood Tracking App study is a small randomized trial of acceptability and usability of a mobile phone mood tracking application (mobile app) among women with depressed mood in pregnancy. The study will be assessing the perceived value and usability of this tool in pregnancy over eight week...
What is the current status of trial NCT02761720?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2015-02.
What conditions does trial NCT02761720 study?
This clinical trial studies the following conditions: Depression, Mood Disorders.
What interventions are being tested in trial NCT02761720?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT02761720?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02761720 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.